Ratnakar Securities Limited.

NEPHROCARE HEALTH SERVICES LTD.

NSE : NEPHROPLUSBSE : 544647ISIN CODE : INE428V01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE581.5545.8 (+8.55 %)

PREV CLOSE ( ) 535.75

OPEN PRICE ( ) 565.60

BID PRICE (QTY) 581.55 (17)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 556200

TODAY'S LOW / HIGH ( )545.00 603.25

52 WK LOW / HIGH ( )445 603.25

Select year

Particulars	Mar2025	Mar2024	Mar2023
Operational & Financial Ratios
Earnings Per Share (Rs)	380.15	200.87	-67.75
CEPS(Rs)	158.15	104.34	40.33
DPS(Rs)	0.00	0.00	0.00
Book NAV/Share(Rs)	3217.49	2309.53	2167.32
Tax Rate(%)	23.26	-5.95	-37.23
Margin Ratios
Core EBITDA Margin(%)	22.05	17.82	11.11
EBIT Margin(%)	14.33	9.42	1.76
Pre Tax Margin(%)	11.57	5.86	-1.96
PAT Margin (%)	8.88	6.21	-2.70
Cash Profit Margin (%)	18.47	16.12	8.02
Performance Ratios
ROA(%)	7.63	4.91	-1.81
ROE(%)	13.81	9.00	-3.13
ROCE(%)	14.76	8.59	1.31
Asset Turnover(x)	0.86	0.79	0.67
Sales/Fixed Asset(x)	1.22	1.19	1.13
Working Capital/Sales(x)	2.89	3.84	2.92
Efficiency Ratios
Fixed Capital/Sales(x)	0.82	0.84	0.88
Receivable days	113.27	116.42	132.30
Inventory Days	12.69	16.82	21.93
Payable days	172.42	123.18	110.84
Valuation Parameters
PER(x)	0.00	0.00	0.00
PCE(x)	0.00	0.00	0.00
Price/Book(x)	0.00	0.00	0.00
Yield(%)
EV/Net Sales(x)	0.10	0.33	0.43
EV/Core EBITDA(x)	0.42	1.71	3.43
EV/EBIT(x)	0.70	3.51	24.37
EV/CE(x)	0.09	0.29	0.32
M Cap / Sales	0.00	0.00	0.00
Growth Ratio
Net Sales Growth(%)	33.50	29.47	0.00
Core EBITDA Growth(%)	65.13	100.61	0.00
EBIT Growth(%)	102.98	594.53	0.00
PAT Growth(%)	90.98	398.02	0.00
EPS Growth(%)	89.25	396.48	0.00
Financial Stability Ratios
Total Debt/Equity(x)	0.40	0.60	0.52
Current Ratio(x)	1.92	1.61	1.86
Quick Ratio(x)	1.83	1.50	1.71
Interest Cover(x)	5.20	2.64	0.47
Total Debt/Mcap(x)

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Financial Ratios

NEPHROCARE HEALTH SERVICES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES